Dashboard Tools Market News Investing Ideas Pricing
Search 100,000+ stocks...
Sign Up
Log in
Immunitybio Inc banner

Immunitybio Inc
NASDAQ:IBRX

Watchlist Manager
Immunitybio Inc Logo
Immunitybio Inc
NASDAQ:IBRX
Watchlist
Price: 7.38 USD -8.55% Market Closed
Market Cap: $7.6B
Write Note Create Alert Ask AI
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

IBRX Price Targets Summary
Immunitybio Inc

Wall Street analysts forecast IBRX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for IBRX is 13.06 USD with a low forecast of 7.07 USD and a high forecast of 25.2 USD.

IBRX Lowest Forecast
Wall Street Target
7.07 USD
-4% Downside
IBRX Average Forecast
Wall Street Target
13.06 USD
77% Upside
IBRX Highest Forecast
Wall Street Target
25.2 USD
241% Upside
Lowest
Price Target
7.07 USD
4% Downside
Average
Price Target
13.06 USD
77% Upside
Highest
Price Target
25.2 USD
241% Upside
Immunitybio Inc Competitors:
Price Targets
MRVL
Marvell Technology Group Ltd
20% Upside
VIAV
Viavi Solutions Inc
-23% Downside
RCKT
Rocket Pharmaceuticals Inc
68% Upside
WASH
Washington Trust Bancorp Inc
8% Upside
MRVL
Marvell Technology Group Ltd
20% Upside
VIAV
Viavi Solutions Inc
-23% Downside
RCKT
Rocket Pharmaceuticals Inc
68% Upside
WASH
Washington Trust Bancorp Inc
8% Upside
WINA
Winmark Corp
30% Upside
APA
APA Corp (US)
-37% Downside

Revenue
Forecast

60% / Year
Past Growth
122% / Year
Estimated Growth
Estimates Accuracy
23%
Average Beat
60% / Year
Past Growth
122% / Year
Estimated Growth
Estimates Accuracy
23%
Average Beat

For the last 11 years the compound annual growth rate for Immunitybio Inc's revenue is 60%. The projected CAGR for the next 3 years is 122%.

What are analyst estimates?

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss

What are analyst estimates?

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-76%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-76%
Average Miss

What are analyst estimates?

See Also

Summary
IBRX intrinsic value, competitors valuation, and company profile.
DCF Valuation
IBRX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
IBRX stock valuation using valuation multiples.
Wall Street Estimates
IBRX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
IBRX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is IBRX's stock price target?
Price Target
13.06 USD

According to Wall Street analysts, the average 1-year price target for IBRX is 13.06 USD with a low forecast of 7.07 USD and a high forecast of 25.2 USD.

What is Immunitybio Inc's Revenue forecast?
Projected CAGR
122%

For the last 11 years the compound annual growth rate for Immunitybio Inc's revenue is 60%. The projected CAGR for the next 3 years is 122%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 326,500+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

AI Assistant
Get AI-powered insights for any company or topic.
Open AI Assistant
Other Tools
Stock Screener
Discover stocks
Stock Comparison
Smarter decisions through side-by-side analysis
Intrinsic Value Calculator
Discover the true worth of your stocks
DCF Value Calculator
Harness the power of DCF

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett